Scientific Background and Reference Sources
Al-Haddad, M. A., Kowalski, T., Siddiqui, A., Mertz, H. R., Mallat, D., Haddad, N., . . . Catalano, M. F. (2015). Integrated molecular pathology accurately determines the malignant potential of pancreatic cysts. Endoscopy, 47(2), 136-142. doi:10.1055/s-0034-1390742
Beaudenon-Huibregtse, S., Alexander, E. K., Guttler, R. B., Hershman, J. M., Babu, V., Blevins, T. C., . . . Labourier, E. (2014). Centralized molecular testing for oncogenic gene mutations complements the local cytopathologic diagnosis of thyroid nodules. Thyroid, 24(10), 1479-1487. doi:10.1089/thy.2013.0640
Diagnostics, I. (2017). Interpace Diagnostics Molecular Diagnostics. Retrieved from http://www.interpacediagnostics.com/
Elta, G. H., Enestvedt, B. K., Sauer, B. G., & Lennon, A. M. (2018). ACG Clinical Guideline: Diagnosis and Management of Pancreatic Cysts. Am J Gastroenterol, 113(4), 464-479. doi:10.1038/ajg.2018.14
Finkelstein, S. D., & Finkelstein, P. A. (2001). United States Patent No. patft.uspto.gov: U. S. Patent.
Kowalski, T., Siddiqui, A., Loren, D., Mertz, H. R., Mallat, D., Haddad, N., . . . Al-Haddad, M. A. (2016). Management of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of Malignancy. J Clin Gastroenterol, 50(8), 649-657. doi:10.1097/mcg.0000000000000577
Labourier, E., Shifrin, A., Busseniers, A. E., Lupo, M. A., Manganelli, M. L., Andruss, B., . . . Beaudenon-Huibregtse, S. (2015). Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology. J Clin Endocrinol Metab, 100(7), 2743-2750. doi:10.1210/jc.2015-1158
Loren, D., Kowalski, T., Siddiqui, A., Jackson, S., Toney, N., Malhotra, N., & Haddad, N. (2016). Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort. Diagn Pathol, 11. doi:10.1186/s13000-016-0462-x
Malhotra, N., Jackson, S.A., Freed, L.L., et al (2014). The added value of using mutational profiling in addition to cytology in diagnosing aggressive pancreaticobiliary disease: review of clinical cases at a single center. BMC Gastroenterol., 14:135.
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma, version 1.2017. Retrieved online on April 20, 2017 from http://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf
National Comprehensive Cancer Network (2016). NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers, version 1.2016. Retrieved online on April 20, 2017 from http://www.nccn.org/professionals/physician_gls/pdf/cns.pdf
National Comprehensive Cancer Network (2017). NCCN Clinical Practice Guidelines in Oncology: Esophageal and Esophagogastric Junction Cancers, version 1.2017. Retrieved online on April 20, 2017 from http://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf
National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers, version 1.2017. Retrieved online on April 20, 2017 from http://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf
Panarelli, N. C., Sela, R., Schreiner, A. M., Crapanzano, J. P., Klimstra, D. S., Schnoll-Sussman, F., Yantiss, R. K. (2012). Commercial molecular panels are of limited utility in the classification of pancreatic cystic lesions. Am J Surg Pathol, 36(10), 1434-1443. doi:10.1097/PAS.0b013e31825d534a
Singhi, A. D., Zeh, H. J., Brand, R. E., Nikiforova, M. N., Chennat, J. S., Fasanella, K. E., . . . McGrath, K. (2016). American Gastroenterological Association guidelines are inaccurate in detecting pancreatic cysts with advanced neoplasia: a clinicopathologic study of 225 patients with supporting molecular data. Gastrointest Endosc, 83(6), 1107-1117.e1102. doi:10.1016/j.gie.2015.12.009
Spechler, S.J., Sharma, P., Souza, R.F. et al (2011). American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology, 140(3):1084-1091.
Tanaka, M., Fernandez-Del Castillo, C., Kamisawa, T., Jang, J. Y., Levy, P., Ohtsuka, T., . . . Wolfgang, C. L. (2017). Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology, 17(5), 738-753. doi:10.1016/j.pan.2017.07.007
Trikalinos, T.A., Terasawa, T., Raman, G., et al (2010). A systematic review of loss-of-heterozygosity based topographic genotyping with PathfinderTG: Technology Assessment Report. Retrieved online on April 20, 2017 from https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id68ta.pdf
Vege, S.S., Ziring, B., Jain, R., and Moayyedi, P. (2015) Clinical Guidelines Committee. American Gastroenterological Association Institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts. Gastroenterology, 148(4):819-822.